Position in FATE
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$44,097
New position
Shares Held
36,748
first reported quarter
Ownership
0.032%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.11157069772504626.ToString("F0")%
Shared 0.ToString("F0")%
None 99.88842930227494.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Abel Hall, LLC holds $10,850,864 across 52 Biotechnology names. FATE ranks #39 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,271 | $665,330 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,474 | $658,199 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
5,842 | $568,134 | |
| 4 | INSM |
INSMED Inc
|
3,090 | $505,276 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
7,910 | $495,957 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
4,258 | $448,793 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
1,392 | $448,488 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
8,278 | $436,416 |
All Filings in FATE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,097 | 36,748 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||